Meropenem Kalceks

Meropenem, the active ingredient in Meropenem Kalceks, is a carbapenem antibiotic presented as an injectable powder for intravenous use. It treats severe bacterial infections, including intra‑abdominal, urinary tract, and respiratory infections, in hospitalized adult and pediatric patients. It is manufactured according to EU standards and is indicated for use in severe sepsis and septic shock.

GNH USA supplies Meropenem Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Meropenem is a carbapenem antibiotic used to treat serious bacterial infections.

- Complicated intra‑abdominal infections: effective bacterial eradication in patients with intra‑abdominal infection requiring broad‑spectrum coverage. - Complicated urinary tract infections: clears resistant uropathogens in complicated UTIs. - Hospital‑acquired pneumonia: provides coverage against multidrug‑resistant respiratory pathogens. - Ventilator‑associated pneumonia: treats ventilator‑related lung infections with high efficacy. - Meningitis: penetrates the cerebrospinal fluid to eradicate causative bacteria. - Severe sepsis and septic shock: rapid bactericidal action supports hemodynamic stabilization.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be self‑limiting or indicate colitis. - Rash: skin erythema or urticaria. - Elevated liver enzymes: transient hepatic enzyme rise.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Anaphylaxis: acute hypersensitivity reaction requiring emergency care. - Renal impairment: acute kidney injury in susceptible individuals.

Use meropenem with careful clinical monitoring.

- Assess renal function: dose adjustment may be required in renal insufficiency. - Monitor for seizures: avoid in patients with a history of epilepsy or CNS disease. - Review antibiotic susceptibility: ensure the pathogen is susceptible before continuation. - Use caution with concomitant valproic acid: increased risk of reduced seizure control. - Evaluate hepatic function: monitor liver enzymes during prolonged therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines.

Major Interactions (Avoid): - Valproic acid: may reduce antiepileptic efficacy and increase seizure risk. - Other carbapenems: competitive inhibition may diminish therapeutic effect. - High‑dose aminoglycosides: combined nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Warfarin: occasional INR alterations; check coagulation status regularly.